By More than half of the patients who were prescribed medication to treat opioid use disorder through a virtual program established during the pandemic continued with their treatment at least a month later, according to a NEJM Catalyst study from researchers at the Perelman School of Medicine at the University of Pennsylvania.
Half of patients in telemedicine program for opioid use disorder current with medication a month later
Research scientist with gloves holding blood sample on glass in laboratory. Biology doctor analyzing plasma dna for medical discovery in pharmaceutical industry. Science equipment on desk
Comments